Clinical Trial Update: PEA vs. Placebo for Major Depression [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating PEA versus placebo for major depression, with bipolar depression and major depressive disorder as conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Depression
• Major Depressive Disorder

Drugs mentioned

• PEA (palmitoylethanolamide)

Snippet

Sponsor: The Israeli Medical Center for Alzheimer's | Conditions: Bipolar Depression, Major Depressive Disorder | Phase 2 | Status: UNKNOWN